Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer

被引：63
|
作者：
Gridelli, C [1 ]
Maione, P
Castaldo, V
Rossi, A
机构：
[1] SG Moscati Hosp Via Circumvallaz, Div Med Oncol, I-83100 Avellino, Italy
[2] SG Moscati Hosp Via Circumvallaz, Direz Sanitaria, I-83100 Avellino, Italy
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 89卷 / 10期
关键词：
NSCLC; gefitinib; elderly; poor PS patients;
D O I：
10.1038/sj.bjc.6601387
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Elderly and poor performance status advanced non-small-cell lung cancer ( NSCLC) patients often tolerate chemotherapy poorly. Special approaches are needed for these patient populations. Gefitinib ( Iressa) was used in 59 elderly and/or unfit NSCLC pretreated patients participating in a compassionate use programme showing some activity and good tolerability.
引用
收藏
页码：1827 / 1829
页数：3
相关论文
共 50 条
  • [21] Use of Cetuximab After Failure of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
    Wu, Jenn-Yu
    Yang, Chih-Hsin
    Hsu, Ya-Chieh
    Yu, Chong-Jen
    Chang, Shih-Han
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    CLINICAL LUNG CANCER, 2010, 11 (04) : 257 - 263
  • [22] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Grossi, Francesco
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Defferrari, Carlotta
    Brianti, Annalisa
    Barletta, Giulia
    Genova, Carlo
    Murolo, Carmelina
    Cosso, Maurizio
    Fontanini, Gabriella
    Boldrini, Laura
    Truini, Mauro
    Pronzato, Paolo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1407 - 1412
  • [23] Treatment of advanced non-small-cell lung cancer in the elderly
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Ferrara, Marianna Luciana
    Castaldo, Vincenzo
    Palazzolo, Giovanni
    Mazzeo, Nicole
    LUNG CANCER, 2009, 66 (03) : 282 - 286
  • [24] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Francesco Grossi
    Erika Rijavec
    Maria Giovanna Dal Bello
    Carlotta Defferrari
    Annalisa Brianti
    Giulia Barletta
    Carlo Genova
    Carmelina Murolo
    Maurizio Cosso
    Gabriella Fontanini
    Laura Boldrini
    Mauro Truini
    Paolo Pronzato
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1407 - 1412
  • [25] Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    Tsurutani, J
    Dennis, PA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23): : 1795 - 1795
  • [26] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer - Reply
    Cappuzzo, F
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) : 462 - 463
  • [27] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zheng-Tao Zhou
    Xin-Hua Xu
    Qing Wei
    Ming-qian Lu
    Jie Wang
    Cai-Hong Wen
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 1123 - 1127
  • [28] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zhou, Zheng-Tao
    Xu, Xin-Hua
    Wei, Qing
    Lu, Ming-qian
    Wang, Jie
    Wen, Cai-Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) : 1123 - 1127
  • [29] Gefitinib Monotherapy in Advanced non-small-cell Lung Cancer: A Retrospective Analysis
    Shrestha, S.
    Joshi, P.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2012, 52 (02) : 66 - 71
  • [30] Gefitinib ('Iressa'): a new therapy for advanced non-small-cell lung cancer
    Reck, M
    Gatzemeier, U
    RESPIRATORY MEDICINE, 2005, 99 (03) : 298 - 307
12345